Regrettably procalcitonin lacks adverse predictive value so most literature supports its use in diagnosing pulmonary bacterial infections and for antibiotic de-escalation. Whilst it's been adopted commonly and in many different options, the GCS score just isn't meant for quantitative use. Scientific administration decisions shouldn't be based